4 years ago

DnaNudge Secures $60M Series A Funding to Expand Genetic Testing Solutions

  • DnaNudge, a London-based genetics testing and medical diagnostics company, raised $60 million in Series A funding led by Ventura Capital with participation from Bank Julius Baer

  • DnaNudge uses DNA to nudge people toward healthier choices while shopping, with its Nutrition service analyzing genetic profiles to identify health traits like obesity and diabetes

  • The company plans to use the funding to accelerate the deployment of its rapid genetic testing solutions, including its RT-PCR COVID-19 test, which is in use globally

  • DnaNudge is also providing its COVID-19 testing as a private consumer service and is playing a role in the safe return of the UK's cultural sector.

      • ProblemHealthcare

      "People struggle to make healthy lifestyle choices, often lacking personalized guidance based on their individual needs."

      Solution

      "DnaNudge provides personalized health recommendations based on an individual's DNA and lifestyle factors, helping people make healthier choices related to nutrition and overall wellbeing."

      Covered on